Clinical Trial Update: Measuring and Mapping Cognitive Decline After Brain Radiosurgery

View source ↗

Summary

A University of Nottingham-led clinical trial is recruiting to measure and map cognitive decline after brain radiosurgery in patients with brain metastases or m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Meningioma

Snippet

Sponsor: University of Nottingham | Conditions: Brain Metastases, Meningiomas | Status: RECRUITING